- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00749905
Low Fiber Diet for Bowel Preparation for Colon Capsule Examination
June 12, 2018 updated by: Prof. Shomron BenHorin, Sheba Medical Center
A Prospective Randomized Controlled Investigator-blinded Study of Low Fiber Diet for Bowel Preparation for Colon Capsule Examination
A prospective randomized controlled investigator-blinded study to compare efficacy of low fiber diet for 5 days versus regular diet, both as adjunct to one day clear liquid diet and standard bowel preparation for colon capsule examination
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
75
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tel-Hashomer, Israel
- Sheba Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age >18 and <75
- Colon study indicated for colo-rectal carcinoma screening
- After colonoscopy for any indication failed due to technical causes
- Patients who decline an indicated colonoscopy
Exclusion Criteria:
- Significant heart failure (NYHA grade III-IV)
- Renal failure (Creatinine > 1.2 mg/dl)
- Known or suspected intestinal strictures
- Known or suspected mesenteric adhesions
- History suggestive of bowel obstruction
- Vomiting and/or aspirations
- Symptoms of dysphagia
- Pace-maker or AICD implanted
- Known allergy or intolerance to any of the study drugs
- Pregnancy
- Illicit drug abuse or alcoholism
- Inability to provide an informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
Low fiber diet for 5 days prior to procedure
|
Low fiber diet for 5 days prior to colon capsule
|
|
Active Comparator: 2
regular diet
|
Regular diet until 1 day before colon capsule
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Colon cleanliness
Time Frame: one week from capsule examination
|
one week from capsule examination
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Tolerability of preparations
Time Frame: within 1 day of completing preparation
|
within 1 day of completing preparation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2009
Primary Completion (Actual)
July 1, 2009
Study Completion (Actual)
December 1, 2009
Study Registration Dates
First Submitted
September 8, 2008
First Submitted That Met QC Criteria
September 8, 2008
First Posted (Estimate)
September 9, 2008
Study Record Updates
Last Update Posted (Actual)
June 14, 2018
Last Update Submitted That Met QC Criteria
June 12, 2018
Last Verified
June 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- SHEBA-08-5217-SBH-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.